Scott N Gettinger (Scott Gettinger)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 23

Top Topics

Combination Therapy

Epidermal Growth Factor Receptor

Top Venues

Cancer research

Cancer discovery

JCO clinical cancer informatics

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Bomiao Hu, Marc Wiesehöfer, Fernando J de Miguel, Zongzhi Z Liu, Lok Hei Chan, Jungmin Choi, Mary Ann Melnick, Anna Arnal-Estape, Zenta Walther, Dejian Zhao, Francesc Lopez, Anna Wurtz, Guoping Cai, Rong Fan, Scott N Gettinger, Andrew Z Xiao, Qin Yan, Robert J Homer, Don X Nguyen, Katerina Politi
ASCL1 Drives Tolerance to Osimertinib in EGFR Mutant Lung Cancer in Permissive Cellular Contexts. Cancer research (2024)
Edwin Roger Parra Cuentes, Jianhua Zhang, Dzifa Yawa Duose, Edgar G Kozlova, Mary W Redman, Hong Chen, Ganiraju C Manyam, Gayatri Kumar, Jianhua Zhang, Xingzhi Song, Rossana Lazcano, Mario L Marques-Piubelli, Caddie Laberiano Fernández, Frank R Rojas Alvarez, Baili Zhang, Len Taing, Aashna Jhaveri, Jacob Geisberg, Jennifer Altreuter, Franziska Michor, James Provencher, Joyce Yu, Ethan Cerami, Radim Moravec, Kasthuri Kannan, Rajyalakshmi Luthra, Gheath Al-Atrash, Hsin-Hui Huang, Hui Xie, Manishkumar Patel, Kai Nie, Jocelyn Harris, Kimberly Argueta, James R Lindsay, Roshni Biswas, Stephen Van Nostrand, Seunghee Kim-Schulze, Jhanelle E Gray, Roy S Herbst, Ignacio I Wistuba, Scott N Gettinger, Karen Kelly, Lyudmila Bazhenova, Sacha Gnjatic, Jiun-Kae Jack Lee, Jianjun Zhang, Cara L Haymaker
Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Edwin Roger Parra Cuentes, Jianhua Zhang, Dzifa Yawa Duose, Edgar G Kozlova, Mary W Redman, Hong Chen, Ganiraju C Manyam, Gayatri Kumar, Jianhua Zhang, Xingzhi Song, Rossana Lazcano, Mario L Marques-Piubelli, Caddie Laberiano Fernández, Frank R Rojas Alvarez, Baili Zhang, Len Taing, Aashna Jhaveri, Jacob Geisberg, Jennifer Altreuter, Franziska Michor, James Provencher, Joyce Yu, Ethan Cerami, Radim Moravec, Kasthuri Kannan, Rajyalakshmi Luthra, Gheath Al-Atrash, Hsin-Hui Huang, Hui Xie, Manishkumar Patel, Kai Nie, Jocelyn Harris, Kimberly Argueta, James R Lindsay, Roshni Biswas, Stephen Van Nostrand, Seunghee Kim-Schulze, Jhanelle E Gray, Roy S Herbst, Ignacio I Wistuba, Scott N Gettinger, Karen Kelly, Lyudmila Bazhenova, Sacha Gnjatic, Jiun-Kae Jack Lee, Jianjun Zhang, Cara L Haymaker
Multi-omics analysis reveals immune features associated with immunotherapy benefit in squamous cell lung cancer patients from Phase III Lung-MAP S1400I trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Edwin Roger Parra Cuentes, Jianhua Zhang, Dzifa Yawa Duose, Edgar G Kozlova, Mary W Redman, Hong Chen, Ganiraju C Manyam, Gayatri Kumar, Jianhua Zhang, Xingzhi Song, Rossana Lazcano, Mario L Marques-Piubelli, Caddie Laberiano Fernández, Frank R Rojas Alvarez, Baili Zhang, Len Taing, Aashna Jhaveri, Jacob Geisberg, Jennifer Altreuter, Franziska Michor, James Provencher, Joyce Yu, Ethan Cerami, Radim Moravec, Kasthuri Kannan, Rajyalakshmi Luthra, Gheath Al-Atrash, Hsin-Hui Huang, Hui Xie, Manishkumar Patel, Kai Nie, Jocelyn Harris, Kimberly Argueta, James R Lindsay, Roshni Biswas, Stephen Van Nostrand, Seunghee Kim-Schulze, Jhanelle E Gray, Roy S Herbst, Ignacio I Wistuba, Scott N Gettinger, Karen Kelly, Lyudmila Bazhenova, Sacha Gnjatic, Jiun-Kae Jack Lee, Jianjun Zhang, Cara L Haymaker
Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Bomiao Hu, Marc Wiesehöfer, Fernando J de Miguel, Zongzhi Z Liu, Lok Hei Chan, Jungmin Choi, Mary Ann Melnick, Anna Arnal-Estape, Zenta Walther, Dejian Zhao, Francesc Lopez, Anna Wurtz, Guoping Cai, Rong Fan, Scott N Gettinger, Andrew Z Xiao, Qin Yan, Robert J Homer, Don X Nguyen, Katerina Politi
ASCL1 Drives Tolerance to Osimertinib in EGFR Mutant Lung Cancer in Permissive Cellular Contexts. Cancer research 84 (8) (2024)
Adam J Schoenfeld, Sylvia M Lee, Bernard Doger, Scott N Gettinger, Simon Haefliger, Ammar Sukari, Sophie Papa, Juan Francisco Rodriguez-Moreno, Friedrich Graf Finckenstein, Rana Fiaz, Melissa Catlett, Guang Chen, Rongsu Qi, Emma L Masteller, Viktoria Gontcharova, Kai He
Lifileucel, an Autologous Tumor-Infiltrating Lymphocyte Monotherapy, in Patients with Advanced Non-Small Cell Lung Cancer Resistant to Immune Checkpoint Inhibitors. Cancer discovery 14 (8) (2024)
Adam J Schoenfeld, Sylvia M Lee, Bernard Doger, Scott N Gettinger, Simon Haefliger, Ammar Sukari, Sophie Papa, Juan Francisco Rodriguez-Moreno, Friedrich Graf Finckenstein, Rana Fiaz, Melissa Catlett, Guang Chen, Rongsu Qi, Emma L Masteller, Viktoria Gontcharova, Kai He
Lifileucel, an Autologous Tumor-infiltrating Lymphocyte Monotherapy, in Patients with Advanced Non-small Cell Lung Cancer Resistant to Immune Checkpoint Inhibitors. Cancer discovery (2024)
Scott N Gettinger, Zihe Song, Karen L Reckamp, Jeffrey A Moscow, Robert C Gray, Victoria Wang, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Xiao-Tang Kong, James V Tricoli, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaherty
Phase II Trial of Afatinib in Patients With EGFR -Mutated Solid Tumors Excluding Lung Cancer: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol A. JCO precision oncology 8 (2024)
Adam J Schoenfeld, Sylvia M Lee, Bernard Doger, Scott N Gettinger, Simon Haefliger, Ammar Sukari, Sophie Papa, Juan Francisco Rodriguez-Moreno, Friedrich Graf Finckenstein, Rana Fiaz, Melissa Catlett, Guang Chen, Rongsu Qi, Emma L Masteller, Viktoria Gontcharova, Kai He
Lifileucel, an Autologous Tumor-Infiltrating Lymphocyte Monotherapy, in Patients with Advanced Non-Small Cell Lung Cancer Resistant to Immune Checkpoint Inhibitors. Cancer discovery 14 (8) (2024)
Bomiao Hu, Marc Wiesehöfer, Fernando J de Miguel, Zongzhi Z Liu, Lok Hei Chan, Jungmin Choi, Mary Ann Melnick, Anna Arnal-Estape, Zenta Walther, Dejian Zhao, Francesc Lopez, Anna Wurtz, Guoping Cai, Rong Fan, Scott N Gettinger, Andrew Z Xiao, Qin Yan, Robert J Homer, Don X Nguyen, Katerina Politi
ASCL1 Drives Tolerance to Osimertinib in EGFR Mutant Lung Cancer in Permissive Cellular Contexts. Cancer research 84 (8) (2024)
Bomiao Hu, Marc Wiesehöfer, Fernando J de Miguel, Zongzhi Z Liu, Lok Hei Chan, Jungmin Choi, Mary Ann Melnick, Anna Arnal-Estape, Zenta Walther, Dejian Zhao, Francesc Lopez, Anna Wurtz, Guoping Cai, Rong Fan, Scott N Gettinger, Andrew Z Xiao, Qin Yan, Robert J Homer, Don X Nguyen, Katerina Politi
ASCL1 Drives Tolerance to Osimertinib in EGFR Mutant Lung Cancer in Permissive Cellular Contexts. Cancer research 84 (8) (2024)
Bomiao Hu, Marc Wiesehöfer, Fernando J de Miguel, Zongzhi Z Liu, Lok Hei Chan, Jungmin Choi, Mary Ann Melnick, Anna Arnal-Estape, Zenta Walther, Dejian Zhao, Francesc Lopez, Anna Wurtz, Guoping Cai, Rong Fan, Scott N Gettinger, Andrew Z Xiao, Qin Yan, Robert J Homer, Don X Nguyen, Katerina Politi
ASCL1 Drives Tolerance to Osimertinib in EGFR Mutant Lung Cancer in Permissive Cellular Contexts. Cancer research 84 (8) (2024)
Adam J Schoenfeld, Sylvia M Lee, Bernard Doger, Scott N Gettinger, Simon Haefliger, Ammar Sukari, Sophie Papa, Juan Francisco Rodriguez-Moreno, Friedrich Graf Finckenstein, Rana Fiaz, Melissa Catlett, Guang Chen, Rongsu Qi, Emma L Masteller, Viktoria Gontcharova, Kai He
Lifileucel, an Autologous Tumor-Infiltrating Lymphocyte Monotherapy, in Patients with Advanced Non-Small Cell Lung Cancer Resistant to Immune Checkpoint Inhibitors. Cancer discovery 14 (8) (2024)
Scott N Gettinger, Zihe Song, Karen L Reckamp, Jeffrey A Moscow, Robert C Gray, Victoria Wang, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Xiao-Tang Kong, James V Tricoli, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaherty
Phase II Trial of Afatinib in Patients With EGFR -Mutated Solid Tumors Excluding Lung Cancer: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol A. JCO precision oncology 8 (2024)
Bomiao Hu, Marc Wiesehöfer, Fernando J de Miguel, Zongzhi Z Liu, Lok Hei Chan, Jungmin Choi, Mary Ann Melnick, Anna Arnal-Estape, Zenta Walther, Dejian Zhao, Francesc Lopez, Anna Wurtz, Guoping Cai, Rong Fan, Scott N Gettinger, Andrew Z Xiao, Qin Yan, Robert J Homer, Don X Nguyen, Katerina Politi
ASCL1 Drives Tolerance to Osimertinib in EGFR Mutant Lung Cancer in Permissive Cellular Contexts. Cancer research 84 (8) (2024)
Bomiao Hu, Marc Wiesehöfer, Fernando J de Miguel, Zongzhi Z Liu, Lok Hei Chan, Jungmin Choi, Mary Ann Melnick, Anna Arnal-Estape, Zenta Walther, Dejian Zhao, Francesc Lopez, Anna Wurtz, Guoping Cai, Rong Fan, Scott N Gettinger, Andrew Z Xiao, Qin Yan, Robert J Homer, Don X Nguyen, Katerina Politi
ASCL1 Drives Tolerance to Osimertinib in EGFR Mutant Lung Cancer in Permissive Cellular Contexts. Cancer research 84 (8) (2024)
Adam J Schoenfeld, Sylvia M Lee, Bernard Doger, Scott N Gettinger, Simon Haefliger, Ammar Sukari, Sophie Papa, Juan Francisco Rodriguez-Moreno, Friedrich Graf Finckenstein, Rana Fiaz, Melissa Catlett, Guang Chen, Rongsu Qi, Emma L Masteller, Viktoria Gontcharova, Kai He
Lifileucel, an Autologous Tumor-Infiltrating Lymphocyte Monotherapy, in Patients with Advanced Non-Small Cell Lung Cancer Resistant to Immune Checkpoint Inhibitors. Cancer discovery 14 (8) (2024)
Shing M Lee, Weijia Fan, Aijin Wang, Riha Vaidya, Mary W Redman, Scott N Gettinger, Lyudmila Bazhenova, Roy S Herbst, Dawn L Hershman, Joseph M Unger
Novel Approaches for Dynamic Visualization of Adverse Event Data in Oncology Clinical Trials: A Case Study Using Immunotherapy Trial S1400-I (SWOG). JCO clinical cancer informatics 7 (2023)
Shing M Lee, Weijia Fan, Aijin Wang, Riha Vaidya, Mary W Redman, Scott N Gettinger, Lyudmila Bazhenova, Roy S Herbst, Dawn L Hershman, Joseph M Unger
Novel Approaches for Dynamic Visualization of Adverse Event Data in Oncology Clinical Trials: A Case Study Using Immunotherapy Trial S1400-I (SWOG). JCO clinical cancer informatics 7 (2023)
Shing M Lee, Weijia Fan, Aijin Wang, Riha Vaidya, Mary W Redman, Scott N Gettinger, Lyudmila Bazhenova, Roy S Herbst, Dawn L Hershman, Joseph M Unger
Novel Approaches for Dynamic Visualization of Adverse Event Data in Oncology Clinical Trials: A Case Study Using Immunotherapy Trial S1400-I (SWOG). JCO clinical cancer informatics 7 (2023)
Shing M Lee, Weijia Fan, Aijin Wang, Riha Vaidya, Mary W Redman, Scott N Gettinger, Lyudmila Bazhenova, Roy S Herbst, Dawn L Hershman, Joseph M Unger
Novel Approaches for Dynamic Visualization of Adverse Event Data in Oncology Clinical Trials: A Case Study Using Immunotherapy Trial S1400-I (SWOG). JCO clinical cancer informatics 7 (2023)
Shing M Lee, Weijia Fan, Aijin Wang, Riha Vaidya, Mary W Redman, Scott N Gettinger, Lyudmila Bazhenova, Roy S Herbst, Dawn L Hershman, Joseph M Unger
Novel Approaches for Dynamic Visualization of Adverse Event Data in Oncology Clinical Trials: A Case Study Using Immunotherapy Trial S1400-I (SWOG). JCO clinical cancer informatics 7 (2023)
Hossein Borghaei, Scott N Gettinger, Everett E Vokes, Laura Q M Chow, Marco Angelo Burgio, Javier De Castro Carpeño, Adam Pluzanski, Arrieta Oscar, Osvaldo Arén Frontera, Rita Chiari, Charles Butts, Joanna Wójcik-Tomaszewska, Bruno Coudert, Marina Chiara Garassino, Neal Ready, Enriqueta Felip Font, Miriam Alonso García, David Michael Waterhouse, Manuel Dómine, Fabrice Barlesi, Scott Antonia, Markus Wohlleber, David E Gerber, Grzegorz Czyzewicz, David R Spigel, Lucio Crino, Wilfried Enst Erich Eberhardt, Ang Li, Sathiya Marimuthu, Julie Brahmer
Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (7) (2021)